No headlines found.
ALT5 Sigma Corporation Issues Stockholder Letter and Provides Corporate Update
ACCESS Newswire (Mon, 23-Feb 8:00 AM ET)
ALT5 Sigma Corporation Appoints Dr. Adel Elmessiry to Board of Directors
ACCESS Newswire (Thu, 12-Feb 8:00 AM ET)
Business Wire (Thu, 29-Jan 8:00 AM ET)
ALT5 Sigma Corporation to Join Global Leaders at Inaugural World Liberty Forum at Mar-a-Lago
Business Wire (Tue, 27-Jan 8:00 AM ET)
Business Wire (Wed, 21-Jan 8:00 AM ET)
ALT5 Sigma Corporation Restores Compliance with Nasdaq Periodic Filing Requirements
Business Wire (Wed, 14-Jan 8:00 AM ET)
ALT5 Sigma Corporation Reports Q3 2025 Financial Results and Significant Milestones
Business Wire (Mon, 12-Jan 8:23 AM ET)
ALT5 Sigma Corp. Reports Company Record Annual Transaction Volume of $3.4 Billion in 2025
Business Wire (Thu, 8-Jan 8:00 AM ET)
Business Wire (Mon, 5-Jan 8:00 AM ET)
PRNewswire (Tue, 30-Dec 9:30 AM ET)
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
Alt5 Sigma trades on the NASDAQ stock market under the symbol ALTS.
As of March 18, 2026, ALTS stock price declined to $1.37 with 1,344,995 million shares trading.
ALTS has a beta of 0.05, meaning it tends to be less sensitive to market movements. ALTS has a correlation of 0.00 to the broad based SPY ETF.
ALTS has a market cap of $172.89 million. This is considered a Micro Cap stock.
Last quarter Alt5 Sigma reported $8 million in Revenue and $.28 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.64.
The top ETF exchange traded funds that ALTS belongs to (by Net Assets): VTI, VXF, SCHA, ITOT, IWC.
ALTS has underperformed the market in the last year with a price return of -69.7% while the SPY ETF gained +17.9%. However, in the short term, ALTS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.5% vs -1.2% return in SPY. But in the last 2 weeks, ALTS shares have been beat by the market, returning -6.2% compared to an SPY return of -2.8%.
ALTS support price is $1.31 and resistance is $1.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALTS shares will trade within this expected range on the day.